DailyIQ
|
Sector:Consumer DefensiveAll sectors
Last updated 4 minutes ago

BG·Bunge Global SA

$.
-. (-.%)
After Hours
High
$116.18
Open
$114.23
Market Cap
22.04B
52W High
$134.87
Low
$112.68
P. Close
$113.63
P/E
32.28
52W Low
$71.60
Fwd P/E
10.19
DailyIQ Est.
$145.32
Technical Score (1D)
45
NEUTRAL
News Sentiment
68
BULLISH
Analysts expect Bunge Global’s Q2 earnings to show a double‑digit jump in EPS, driven by higher commodity prices and efficient cost management, which could lift the stock ahead of the release. Argus Research’s recent upgrade to a $116 target price reflects confidence in that earnings trajectory, suggesting potential upside if the company meets the forecast. However, a conflicting downgrade to $101 earlier in the week cited a weaker earnings outlook, rising operating costs, and intensified competition, creating uncertainty about the company’s near‑term valuation. The scheduled Q2 2026 earnings release and accompanying conference call, announced months ago, will be the key event for confirming revenue and margin details. Bunge’s investment in precision agriculture, crop analytics, automation, and biotechnology is positioned to enhance yield efficiency and resilience amid weather volatility, potentially translating into higher revenue streams. The company’s expansion into crop nutrition and sustainable food solutions aligns with growing demand for data‑driven farming, which could improve margins if adoption accelerates. Commodity price swings remain a key risk factor, as they directly influence Bunge’s input costs and product pricing power. Investors should monitor the earnings conference call for any updates on cost control measures and competitive positioning, as these will clarify whether the higher target price is justified. Finally, watch for any guidance revisions or product launch updates post‑earnings, which could signal further upside or downside potential in the next 1–10 trading days.
Earnings Summary
Bunge Limited is a global agribusiness and food company that operates through four core segments—Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy—providing a critical link in the supply chain for animal feed, food processors, and biofuel producers within the consumer defensive farm products sector. In the most recent two quarters, Bunge’s revenue in Q1 2026 was $21.861 billion, slightly below the $22.155 billion reported in Q3 2025 but on track to meet the $22.351 billion estimate for Q2 2026; the company’s Q1 2026 EPS of $1.83 beat the $0.874 estimate, while EPS for Q2 2026 is pending. Compared to the prior two quarters, revenue has remained relatively flat with a modest decline in Q1 2026, whereas EPS has shown a mixed trend, falling from $2.27 in Q3 2025 to $1.83 in Q1 2026. Historically, Bunge has delivered consistent revenue growth year over year, with a notable $8.7 billion increase from Q4 2024 to Q1 2026, yet EPS has fluctuated, achieving beats in four of the last five quarters and missing only in Q4 2024. Recent news highlights the company’s upcoming Q2 2026 earnings release, which analysts expect to feature a double‑digit EPS jump driven by higher commodity prices and efficient cost management; the release will also likely focus on commodity‑price impacts, supply‑chain developments, and the company’s AgTech investments in precision agriculture, crop nutrition, and sustainable food solutions. Investors should watch for guidance on commodity exposure, supply‑chain resilience, and the monetization of AgTech initiatives, as well as any updates on capital allocation, dividend policy, or strategic acquisitions that could influence Bunge’s valuation and long‑term growth trajectory.

EPS

EstBeatMiss
$0.66$1.12$1.57$2.03$2.48Q4'24Q1'25Q2'25Q3'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$1.93 - -
Q1'26$0.87$1.83+109.4%
Q3'25$1.97$2.27+15.3%
Q2'25$1.08$1.31+20.9%
Q1'25$1.31$1.81+38.3%
Q4'24$2.25$2.13-5.3%

Revenue

EstBeatMiss
$9.9B$13.7B$17.6B$21.4B$25.3BQ4'24Q1'25Q2'25Q3'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$23.5B - -
Q1'26$23.4B$21.9B-6.4%
Q3'25 - $22.2B -
Q2'25 - $12.8B -
Q1'25 - $11.6B -
Q4'24 - $13.5B -
Full Earnings BreakdownEstimates, actuals, guidance, and historical context
→

Market Data

BG Stock Snapshot

BG is currently trading at $113.51, giving Bunge Global SA a market cap of 22.04B and a P/E ratio of 32.3. Today's range spans $112.68–$116.18, with shares opening at $114.23 and moving down $0.12 (0.1%) from the prior close. DailyIQ's technical score sits at 45/100 (HOLD) with a news sentiment reading of 68/100.

Over the past year BG has traded between $71.60 and $134.87 - the current price is +58.5% off the 52-week low and -15.8% from the high. 22 analysts cover the stock with a Buy consensus and a mean 12-month target of $141.44 (range $116.00–$150.00), implying upside of +24.6%.

BG is in a holding pattern - 45/100 technical score, HOLD signal, price at $113.51 (in the middle of its 52-week range), sentiment bullish at 68/100. (P/E: 32.3) At 22.04B in Consumer Defensive market cap, HOLD phases like this are where the thesis is re-evaluated and position sizing decisions get made by both longs and shorts. Annual range: $71.60–$134.87. The next catalyst, not the current setup, determines the exit from this range.

In neutral phases, large-cap Consumer Defensive names like BG are often where sector rotation debates play out quietly — at 22.04B in capitalization, the stock receives incremental allocation from funds reducing mega-cap exposure without the volatility of a small-cap entry. The 45/100 (HOLD) and bullish sentiment (68/100) at $113.51 (in the middle of its 52-week range) describe a stock that is being considered rather than avoided.